Ann: Quarterly Cash Flow and Summary of Activities, page-43

First 43 Last

Share
Profile

Follow
TitusPullo

4,690 Posts.

72

23/10/19

15:09

Post #: 41032784
Share

Originally posted by Just_a_guy ↑

i was initially very interested in ime because of South America/developing world.
They have a clear first mover advantage in South America and as the presentation suggests, they are replacing archaic systems including wet film. This provides a great tailwind.

So why on earth are they wasting time and money on aus and America? They don’t have a hope of competing in those markets. The cost of pacs/ris for a radiology clinic is a tiny tiny fraction of revenue in developed countries, and therefore radiology providers are going to favour efficiency over cost (except sometimes in the public health sector in aus but care stream and cdn are competitors in that space too). So ime trying to undercut their bigger competitors who have more scale means they are up against an impossible task in my view. They can’t be the most functional or efficient provider because the r&d spend of their competitors is many multiples of ime’s revenue.

Cybically, i think they are signing up a hicksville mobile ultrasound company in aus and applying for fda to help their share price to help them raise capital.

so that brings us back to South America. I think ime has a chance of doing very well if their product is reasonable (which I highly doubt given that they were touting ‘new cross referencing ability’ 12 months ago, which is a feature that the better provider have been providing for more then a decade).
If they can keep signing up hospitals in South America and the developing world while the big competitors concentrate on the growing developed world, then they will do well. But the second a better competitor comes along, due to scalability of the software which is increasing by the year, I believe ime will be cactus, and I don’t think carestream/pme/intelerad will need to bother buying ime.

Having said that there is every chance ime 5bags prior, but I just don’t think they have a long term business, and buying this hoping a competitor buys them is rarely a strategy for success.

Expand

Found the webcast. Also refer to being able to increase the prices in SA

Question asked from the 22 min asked re soft launches in the USA and Oz

http://www.openbriefing.com/OB/IMEX...t-Quarter-2019-Appendix-4C-results-/3322.aspx

IME Price at posting: 4.1¢ Sentiment: None Disclosure: Held
5 Upvote

0 Great analysis

Reply

There are more pages in this discussion • 89 more messages in this thread...

First 43 Last

Add IME (ASX) to my watchlist

(20min delay)
Last 45.0¢		Change 0.000(0.00%)		Mkt cap ! $20.49M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
1	11471	45.0¢

Sellers (Offers)

Price($)	Vol.	No.
50.0¢	5000	1

View Market Depth

No.	Vol.	Price($)
1	11471	0.450
1	6252	0.405
1	1250	0.400
0	0	0.000
0	0	0.000

Price($)	Vol.	No.
0.500	5000	1
0.550	18000	1
0.560	10	1
0.605	12727	1
0.660	335	1

Last trade - 16.12pm 22/05/2024 (20 minute delay)

IME (ASX) Chart

Day chart unavailable

Ann: Quarterly Cash Flow and Summary of Activities, page-43

Featured News

Market Close: Comms drags ASX into the red

Australian-listed companies chase the rainbow of the renewable energy market

Market impressed by Fin's 12-metre thick pegmatite discovery in Canada

Portfolio manager claims coking coal could burn bright

Market Update: ASX just afloat with IT on charge and comms flashing red

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Quarterly Cash Flow and Summary of Activities, page-43

Featured News

Top Stories

Market Close: Comms drags ASX into the red

Australian-listed companies chase the rainbow of the renewable energy market

Market impressed by Fin's 12-metre thick pegmatite discovery in Canada

Portfolio manager claims coking coal could burn bright

Market Update: ASX just afloat with IT on charge and comms flashing red

Buyers (Bids)

Sellers (Offers)

Featured News